Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 131Liver Neoplasms 42Carcinoma, Renal Cell 36Leukemia, Myeloid, Acute 32Neoplasm Metastasis 26Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 22Kidney Neoplasms 16Neoplasms 14Prostatic Neoplasms 12Pancreatic Neoplasms 12Recurrence 11Lung Neoplasms 11Colorectal Neoplasms 10Sarcoma 9Melanoma 9Brain Neoplasms 9Myelodysplastic Syndromes 8Glioblastoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia 6Urinary Bladder Neoplasms 5Thyroid Neoplasms 5Rectal Neoplasms 5Multiple Myeloma 5Leukemia, Myelomonocytic, Chronic 5Stomach Neoplasms 4Ovarian Neoplasms 4Liver Diseases 4Gliosarcoma 4

Interventions

Oxaliplatin 3Capecitabine 3Irinotecan 2Gemcitabine 2Cyclophosphamide 2Colonoscopy 2Bupivacaine 2Aspirin 2Ascorbic Acid 2130-nm albumin-bound paclitaxel 2trifluridine tipiracil drug combination 1trametinib 1penpulimab 1pembrolizumab 1lutetium Lu 177 dotatate 1hetrombopag 1halofantrine 1guadecitabine 1gadolinium ethoxybenzyl DTPA 1gadobutrol 1enoxaparin sodium 1copper dotatate CU-64 1camrelizumab 1aumolertinib 1XELOX 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Digestive System Diseases × Sorafenib × Clear all
NCT02292173 2021-06-10

Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
17 enrolled
Gastrointestinal

Digestive System Diseases, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡